Publications

Our publications

Publications

Enhancing antisense efficacy with multimers and multi-targeting oligonucleotides (MTOs) using cleavable linkers
Subramanian RR, Wysk MA, Ogilvie KM, Bhat A, Kuang B, Rockel TD, Weber M, Uhlmann E, Krieg AM. Nucleic Acids Res. 2015 Oct 30;43(19):9123-32. doi: 10.1093/nar/gkv992. Epub 2015 Oct 7.

Genome-wide identification of polycomb-associated RNAs by RIP-seq
Zhao J, Ohsumi TK, Kung JT, Ogawa Y, Grau DJ, Sarma K, Song JJ, Kingston RE, Borowsky M, Lee JT. Mol Cell. 2010 Dec 22;40(6):939-53. doi: 10.1016/j.molcel.2010.12.011.

Presentations

Epigenetic Upregulation of SMN2 Protein by Oligonucleotides Targeting Long non-coding RNA
Kristine M. Hussey, Roshni Davey, Emily Brand, David Knowlton, Brian Schwartz, Romesh R. Subramanian, Jim McSwiggen, Arthur Krieg, Jeff Keil, Herminio Cardona, Christine DiDonato, James Barsoum. Presented at the American Society for Human Genetics (ASHG), Oct. 22-26, 2013, Boston.

Epigenetic Upregulation of SMN2 Protein by Oligonucleotides Targeting Long non-coding RNA
Emily Brand, Roshni Davey, Caroline Woo, Brendan Connolly, David Knowlton, Brian Schwartz, Romesh Subramanian, Carolyn Chrzastowski, Jeff Keil, Christine DiDonato, James Barsoum. Presented at the Families of Spinal Muscular Atrophy (now Cure SMA), June 12-14, 2014, Maryland.

The Identification of Spinal Muscular Atrophy-associated Gene Expression and Antisense RNAs through Stranded RNA-seq
John Brothers II, Caroline Woo, Brian Schwartz, Jim Barsoum, and Andrey Sivachenko. Presented at Advances in Genome Biology & Technology (AGBT), February 26-28, 2015, Florida.

Targeting the GAA-Repeat Region with Oligonucleotides for the Treatment of Friedreich’s Ataxia
Fatih Ozsolak, Kamaljeet Sandhu, Susan Wood,Mark Wysk, Paula Lewis, David Bullough,James Barsoum. Presented at the International Ataxia Research Conference (ARC), March 25-28, 2015, Windsor, England.

A Novel Epigenetic Approach to Treat SMA
Caroline Woo, Roshni Davey, Hans Johannson, Arturo Orjalo, Peter Bialek, David Bullough, James Barsoum. Presented at the Cure SMA Researcher Conference, Friends & Family Session, June 17-20, 2015, Kansas City, MO.

Derepression of the SMN locus by inhibition of lncRNA-mediated PRC2 recruitment with a short steric blocking oligonucleotide
Caroline Woo, Verena Maier, Roshni Davey, James Brennan, Guangde Li, Brian Schwartz, Trevor Okamoto, Hans Johannson, Berhan Mandefro, Dhruv Sareen, Peter Bialek, David Bullough and James Barsoum. Presented at the Harvard Epigenetics Symposium, October 22, 2015, Boston.

Upcoming Events

March 6, 2017, 8:00 am

Cowen and Company 37th Annual Health Care Conference

Presenter: Ronald Renaud, CEO

Boston, MA

May 22, 2017, 8:00 am

UBS Global Healthcare Conference

Presenter: Ronald Renaud, CEO

New York, NY

Past Events

February 14 , 2017

BIO CEO & Investor Conference

Presenter: Ronald Renaud, CEO

Webcast – Replay available until May 15, 2017

New York, NY

December 8 , 2016

Genetic Rx

Presenter: Dr. Tom McCauley, CSO

Panel: Next Generation RNA Technologies

Harvard Medical School, Boston, MA

November 30 , 2016

Piper Jaffray Healthcare Conference

Presenter: Dr. Tom McCauley, CSO

Panel: Genomic 3.0 

New York, NY

November 15 , 2016

EuroTIDES

Presenter: Dr. Bal Bhat, VP Chemistry

Selective Endogenous mRNA Up-Regulation using Single Stranded Oligonucleotides

Berlin, Germany

November 15 , 2016

The 12th Annual Meeting of the Oligonucleotide Therapeutics Society

Sponsor and Participant

Montreal, QC, Canada

November 15 , 2016

FARA Energy Ball and Symposium

Sponsor and Participant

Tampa, FL

November 15 , 2016

The Allied Genetics Conference (TAGC) 2016

Sponsor

Orlando, FL

November 15 , 2016

JMP Securities Life Science Conference

Presenter: Ronald Renaud, CEO

New York, NY

November 15 , 2016

CureSMA Annual Conference

Sponsor and Poster Presentation, A novel epigenetic approach to treat SMA

Anaheim, CA

November 15 , 2016

IBC’s TIDES Oligonucleotide and Peptide Therapeutics

Long Beach, CA

November 15 , 2016

Fight SMA Annual Research Conference

Conference Sponsor and Participant

Alexandria, Virginia

November 15 , 2016

HealthTech: Oligonucleotide Therapeutics and Delivery Conference

Chairperson and Speaker, Bal Bhat, VP Chemistry, Novel Strategies for Endogenous mRNA Upregulation

Cambridge, MA

November 15 , 2016

Keystone Symposium: Chromatin and Epigenetics

Poster presentation, Dr. Caroline Woo, Senior Scientist, A gene upregulation technology that selectively activates genes by targeting PRC2-associated lncRNA.

Whistler, BC, Canada

November 15 , 2016

Cowen and Company 36th Annual Health Care Conference

Speaker: Ron Renaud, CEO

Marriot Copley Place, Boston

November 15 , 2016

The 18th Annual BIO CEO & Investor Conference

Speaker: Ron Renaud, CEO
Webcast

New York, NY

November 15 , 2016

Biotech Showcase 2016

Speaker: Ron Renaud, CEO

November 15 , 2016

International Ataxia Research Conference

Windsor, UK

November 15 , 2016

The 5th Annual Leerink Partners Healthcare Conference

Speaker: Ron Renaud, CEO

Webcast

New York, NY

November 15 , 2016

Long Noncoding RNAs: Marching Toward Mechanism (Keystone Symposium)

Keystone, CO

November 15 , 2016

Cowen & Company 35th Annual Healthcare Conference

San Francisco, CA

November 15 , 2016

JP Morgan Annual Healthcare Conference

San Francisco, CA

November 15 , 2016

ASHG

San Diego, CA

November 15 , 2016

OTS (Oligonucleotide Therapeutics Society)

San Diego, CA

November 15 , 2016

CSHL Conference

Long Island, NY

November 15 , 2016

EpiCongress

Boston, MA

November 15 , 2016

Post-Transcriptional Gene Regulation (Gordon Research Conference)

Newport, RI

November 15 , 2016

FSMA (Families of Spinal Muscular Atrophy)

Washington, DC

November 15 , 2016

American Society of Gene & Cell Therapy

Washington, DC

November 15 , 2016

TIDES

Providence, RI

For more on the latest at RaNA Therapeutics, check out our Media Center.

MEDIA CENTER